ubiquinone

Ubiquinone (CoQ10) is a quinone derivative with a long isoprenoid tail that allows it to diffuse freely within the lipid bilayer of the inner mitochondrial membrane. In the electron transport chain (ETC), it accepts electrons from both Complex I (NADH dehydrogenase) and Complex II (succinate dehydrogenase), becoming reduced to ubiquinol (CoQH2). Ubiquinol then donates these electrons to Complex III (cytochrome bc1 complex), which passes them to cytochrome c and eventually to Complex IV, where oxygen is reduced to water. This electron flow is coupled to proton pumping across the inner mitochondrial membrane, creating the electrochemical gradient used by ATP synthase (Complex V) to generate ATP via oxidative phosphorylation. Because ubiquinone serves as the convergence point for electrons from both Complex I and Complex II pathways, it plays a central role in cellular respiration. Clinically, statins (HMG-CoA reductase inhibitors) can reduce endogenous CoQ10 synthesis since the mevalonate pathway is shared between cholesterol and CoQ10 synthesis, which is proposed as a contributing mechanism to statin-associated myopathy. CoQ10 supplementation has been studied (with mixed evidence) for conditions like statin-induced myalgias, mitochondrial disorders, migraine prophylaxis, and heart failure due to its role in energy production and antioxidant properties. Primary CoQ10 deficiency is a rare cause of mitochondrial disease presenting with encephalomyopathy, nephropathy, or cardiomyopathy. Understanding ubiquinone's position in the ETC is essential for understanding electron transport chain inhibitors (e.g., rotenone inhibits Complex I, antimycin A inhibits Complex III) and metabolic poisons for USMLE purposes.